default author photo

Massimo Di Maio

University of Turin - Department of Oncology

Torino

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

177

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Impact of Platinum-Based Chemotherapy and CTLA-4 Inhibition on Acquired Resistance to First-Line Anti-PD-1/PD-L1 Agents in Non-Small Cell Lung Cancer: A Systematic Review and Reconstructed Individual Patient Data Analysis

Number of pages: 24 Posted: 26 Apr 2025
Università Vita-Salute San Raffaele - San Raffaele Hospital, University of Naples Federico II, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, University of Verona, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele - San Raffaele Hospital, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, University of Naples Federico II, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, University of Turin - Department of Oncology, Harvard University - Dana-Farber Cancer Institute, Imperial College London, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Laboratory of Methodology of Systematic Reviews and Guidelines Production, Istituto di Ricerche Farmacologiche Mario Negri IRCCS - Department of Oncology, AORN dei Colli - Monaldi Hospital and Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele
Downloads 98 (704,534)

Abstract:

Loading...

acquired resistance, platinum-based chemotherapy, CTLA-4 inhibitors, immunotherapy, non-small cell lung cancer

2.

A Multicenter Randomized Phase 4 Trial Comparing Sodium Picosulphate Plus Magnesium Citrate vs Polyethylene Glycol Plus Ascorbic Acid for Bowel PREparation Before COLonoscopy. The PRECOL Trial

Number of pages: 43 Posted: 06 Aug 2020
Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Division of Gastroenterology and Digestive Endoscopy, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Clinical Trial Unit, University of Turin - Department of Oncology, University of Campania Luigi Vanvitelli - Medical Statistics Unit, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Division of Gastroenterology and Digestive Endoscopy, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Division of Gastroenterology and Digestive Endoscopy, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Division of Gastroenterology and Digestive Endoscopy, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Division of Gastroenterology and Digestive Endoscopy, University of Campania Luigi Vanvitelli - Division of Gastroenterology, University of Campania Luigi Vanvitelli - Division of Gastroenterology, Clinica Mediterranea - Division of Gastroenterology, Clinica Mediterranea - Division of Gastroenterology, University of Campania Luigi Vanvitelli - Division of Gastroenterology, ASST Fatebenefratelli-Sacco University Hospital - Division of Gastroenterology, Ospedale Santa Maria di Loreto Nuovo - Digestive Endoscopy Unit, University Hospital San Giovanni di Dio e Ruggi d'Aragona - Division of Gastroenterology, University of Campania Federico II - Department of Public Health, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Division of Gastroenterology and Digestive Endoscopy and Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Clinical Trial Unit
Downloads 41 (1,170,409)

Abstract:

Loading...

colonoscopy; low-volume bowel preparations; Sodium Picosulphate plus Magnesium Citrate; Polyethylene Glycol plus Ascorbic Acid; bowel cleansing; acceptability; compliance; randomized clinical trial

3.

Integration of Translational Research in Phase Iii Trials: A Systemic Review of Breast Cancer Studies in a 5-Year Period

Number of pages: 18 Posted: 15 Jan 2025
Imperial College London, Imperial College London, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Imperial College London, Imperial College London, University of Piemonte Orientale, Fondazione Policlinico Universitario Agostino Gemelli IRCCS and University of Turin - Department of Oncology
Downloads 38 (1,209,354)

Abstract:

Loading...

Translational research, Breast cancer, samples collection